ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Howard G. Welgus sold $127K of Arcutis Biotherapeutics, Inc.
Sold$127,325
$26.93Price
4,728Shares
−12%Stake
What ARQT did after the filing
- The stock from Tue, Oct 20 open, $31.89
- −2.2%
- S&P 500, same days
- −0.8%
3 of 30 trading days so far, to the Oct 23 close.
Traded Thu, Oct 15. Filed Mon, Oct 19, 4:49 PM ET, after the close. Returns use the Oct 20 open and the Oct 23 close. Not investment advice.